Kunming Pharmaceutical a share#snapshot#suffix
| 17,85CNY | 1,62CNY | 9,98% |
WKN: 589978 / ISIN: CNE0000015P8
Kunming Pharmaceutical a share#search#balancesheet/share#balance#headline#income_statement
share#balance#profitpershare- Kunming Pharmaceutical a
| 0,6 23 | 0,5 22 | 0,7 21 | 0,6 20 | 0,6 19 | 0,4 18 | 0,4 17 |
share#balance#salespershare- Kunming Pharmaceutical a
| 10,1 23 | 10,9 22 | 10,8 21 | 10,1 20 |
share#balance#p_e_ratio- Kunming Pharmaceutical a
| 35,6 23 | 27,7 22 | 16,5 21 | 14,4 20 | 18,0 19 | 14,2 18 | 21,8 17 |
Kunming Pharmaceutical Corp (A): share#balance#headline#theshare (in CNY)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie berichtet | 0,59 | 0,51 | 0,67 | 0,60 | 0,60 | 0,44 | 0,42 |
| Gewinn je Aktie unverwässert | 0,59 | 0,51 | 0,67 | 0,60 | - | - | - |
| Gewinn je Aktie verwässert | 0,59 | 0,51 | 0,67 | 0,60 | - | - | - |
| share#balance#cell#dividend_per_share | 0,20 | 0,16 | 0,27 | 0,23 | 0,20 | 0,10 | 0,00 |
| share#balance#cell#dividend_payment | 121,28 | 204,73 | 174,17 | 150,97 | 75,89 | 0,00 | 141,96 |
Kunming Pharmaceutical Corp (A): share#balance#business_ratio (in CNY)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#sales_share | 10,06 | 10,93 | 10,80 | 10,08 | - | - | - |
| share#balance#cell#basic_kgv_end | 35,56 | 27,69 | 16,50 | 14,37 | 17,98 | 14,16 | 21,78 |
| share#balance#cell#diluted_kgv_end | 35,56 | 27,69 | 16,50 | 14,37 | - | - | - |
| share#balance#cell#dividend_ratio | 0,96 | 1,13 | 2,44 | 2,66 | 1,86 | 1,62 | 0,00 |
| share#balance#cell#equity_ratio | 57,10 | 54,38 | 55,55 | 56,67 | 58,29 | 57,29 | 59,54 |
| share#balance#cell#debt_ratio | 42,90 | 45,62 | 44,45 | 43,33 | 41,71 | 42,71 | 40,46 |
Kunming Pharmaceutical Corp (A): share#balance#headline#income_statement (in Mio. CNY)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#sales | 7 628,41 | 8 209,84 | 8 188,56 | 7 652,59 | 8 052,10 | 7 020,43 | 5 790,35 |
| share#balance#cell#sales_change | -7,08 | 0,26 | 7,00 | -4,96 | 14,70 | 21,24 | 14,55 |
| share#balance#cell#sales_gross_profit | 3 283,14 | 3 239,05 | 3 242,65 | 3 242,11 | 3 819,24 | 3 403,06 | 2 525,20 |
| share#balance#cell#sales_gross_profit_change | 1,36 | -0,11 | 0,02 | -15,11 | 12,23 | 34,76 | 33,25 |
| share#balance#cell#operating_income | 471,26 | 431,85 | 410,27 | 439,56 | 451,21 | 375,29 | 372,58 |
| share#balance#cell#operating_income_change | 9,12 | 5,26 | -6,66 | -2,58 | 20,23 | 0,73 | -7,06 |
| share#balance#cell#income_before_tax | 563,81 | 477,54 | 631,76 | 547,58 | 547,88 | 423,35 | 421,91 |
| share#balance#cell#income_before_tax_change | 18,06 | -24,41 | 15,37 | -0,06 | 29,42 | 0,34 | -13,48 |
| share#balance#cell#income_after_tax | 444,68 | 383,18 | 507,67 | 456,86 | 454,31 | 335,54 | 330,10 |
| share#balance#cell#income_after_tax_change | 16,05 | -24,52 | 11,12 | 0,56 | 35,40 | 1,65 | -18,95 |
Kunming Pharmaceutical Corp (A): share#balance#headline#balance (in Mio. CNY)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#total_liabilities | 4 115 | 4 315 | 3 953 | 3 519 | 3 101 | 2 943 | 2 564 |
| Langzeit Gesamtverbindlichk. pro Aktie | 0,34 | 0,29 | 0,29 | 0,16 | 0,13 | 0,38 | 0,47 |
| share#balance#cell#total_equity | 5 477 | 5 143 | 4 940 | 4 603 | 4 334 | 3 949 | 3 774 |
| share#balance#cell#total_equity_change | 6,31 | 4,17 | 7,47 | 6,06 | 9,83 | 4,22 | 3,05 |
| share#balance#cell#total_liabilities_and_equity | 9 591 | 9 457 | 8 893 | 8 122 | 7 435 | 6 892 | 6 338 |
| share#balance#cell#total_liabilities_and_equity_change | 1,42 | 6,35 | 9,49 | 9,24 | 7,88 | 8,73 | 17,32 |
Kunming Pharmaceutical Corp (A): share#balance#headline#other_data (in CNY)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | 0,59 | 0,51 | 0,67 | 0,60 | - | - | - |
| Veränderung Gewinn je Aktie (unverwässert) in % | 15,02 | -23,82 | 11,25 | - | - | - | - |
| Gewinn je Aktie (verwässert) | 0,59 | 0,51 | 0,67 | 0,60 | - | - | - |
| Veränderung Gewinn je Aktie (verwässert) in % | 15,02 | -23,82 | 11,25 | - | - | - | - |
| share#balance#cell#employees | 5 051 | 5 322 | 5 719 | 5 572 | 4 261 | 4 121 | 4 469 |
| share#balance#cell#employees_change | -5,09 | -6,94 | 2,64 | 30,77 | 3,40 | -7,79 | -3,60 |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.